PDA Technical Report No. 85 (TR 85) Enhanced Test Methods for Visible Particle Detection and Enumeration on Elastomeric Closures and Glass Containers (single user digital version)
Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.
- Format
- PDF Single user
- Member Price
- $180.00
- Nonmember Price
- $325.00
- Government Price
- $180.00
Please sign in or become a member to purchase items from the PDA bookstore.
Visual inspection of filled injectable products is an important part of the control strategy of the manufacturing process. It offers a means to improve quality by removing noncompliant units and provides information to drive continuous process improvement.
This technical report addresses test and inspection methods for visible particles in primary packaging components for injectable products, specifically glass vials and syringes, and the elastomeric closures used to seal them. This document is most relevant for ready-to-sterilize (RTS) and ready-to-use (RTU) components since these are not subjected to a further cleaning process immediately before use.
These studies and methods were developed as part of a larger initiative to eliminate visible particles in injectable products. The test and inspection methods discussed within this report are the first step in a standard-setting process. Once test and inspection methods are available, accepted, and implemented, they can be used to assess process capability and establish meaningful process control limits. Without reliable measurements, reliable control limits are not possible.
An overview of this initiative was published previously, and a detailed analysis of particle entry points to the manufacturing process was subsequently published, as follows:
- * Achieving "Zero" Defects for Visible Particles in Injectables
- * Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations
Available to download. Prior to purchase please view the download instructions and Terms of Usage.
Format: PDF (1 file 2.22 MB)
*To purchase licensing, please contact PDA at info@pda.org.
Table of Contents
Table of Contents:
Click here to download >>> Detailed Table of Contents- Introduction
- Glossary and Abbreviations
- Current State of Visual Inspection for Particles
- Elastomeric Closures Test Method
- Glass Container Inspection Method
- Conclusion
- References
- Appendices
Figures and Tables Index
About the Authors
Tia Bush, Amgen (chair)
John Ayres, MD, Pharma Safety Solutions
Cecile Begat, Bayer
Antonio Burazer, Takeda
Fran DeGrazio, West Pharmaceutical Services
Carol Flynn, MEng, Corning
Abizer Harianawala, Stevanato Group
Paul Kinsey, GSK
Jahanvi Miller, MBA, PDA
Anthony Perry, Schott
John Shabushnig, Ph.D., Insight Pharma Consulting
Xu Song, MEng, Astra Zeneca
Hervé Soukiassian, MEng, BD
Andrew Spasoff, MS, Astra Zeneca
Amy Stanton, Amgen
Dorothee Streich, Ph.D., Bayer
Rick Watson, Merck
Elastomer Sub-team
Ravi Patel, West Pharmaceutical Services (Co- Chair)
John Rech, West Pharmaceutical Services (Co- Chair)
Andrea DeSalvia, Aptar
Wadi Farach, MEng, Amgen
Gert Gregoire, MBA, Datwyler
Lucia Ino, West Pharmaceutical Services
Denise Schnaufer, Merck
Larry Staub, MS, Quality Advisor
Julie Suman, Next Breath
Wadi Farach, MEng, Amgen
Rick Watson, Merck
Glass Sub-Team
Hervé Soukiassian, MEng, BD (Co-Chair)
Paul Kinsey, GSK (Co-Chair)
Alfred Breunig, Nipro Pharma Packaging
Benjamin Coutan, MBA, Gerresheimer
Wadi Farach, MEng, Amgen
Carol Flynn, MEng, Corning Incorporated
Martina Marchioro, Stevanato Group
Didier Morel, BD
Anthony Perry, Schott
Volker Rupertus, Schott AG
Daniele Zuccato, Schott AG